Feinberg Peter 4
4 · Immuneering Corp · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Feinberg Peter
Director
Transactions
- Award
Stock Option
2023-06-14+17,500→ 17,500 totalExercise: $9.32Exp: 2033-06-14→ Class A Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in substantially equal monthly installments over a one-year period with a vesting commencement date of June 14, 2023, and will be fully vested and exercisable on June 14, 2024, or the date of the 2024 annual meeting of stockholders, whichever comes first.